12-10517-RWZ
38
1 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS John Gallagher, Richard Holden, Gerald Lutz, and all others similarly situated, Plaintiffs, vs. Pfizer, Inc., Warner-Lambert Company, and Ranbaxy Inc., Defendants. Case No. ____________________ CLASS ACTION COMPLAINT JURY DEMAND 1. Plaintiffs John Gallagher, Richard Holden and Gerald Lutz (collectively “Plaintiffs”), individually and on behalf of all othe r individuals and entities similarly situated, b y and through their attorneys Berman DeValerio and Zimmerman Reed, PLLP, bring this action against Defendants Pfizer Inc. (“Pfizer”), Warner -Lambert Co. (“Warner -Lambert), and Ranbaxy Inc. (“Ranbaxy”) (collectively “Defendants”), and allege as follows: INTRODUCTION 2. Pfizer is the largest pharmaceutical company in the world and the largest biopharmaceutical company in four global markets. Pfizer’s best selling drug is Li pitor, a drug whose active ingredient atorvastatin calcium is used to treat high cholesterol. 3. Lipitor is the most profitable drug in the history of the pharmaceutical business. Lipitor sales have reached over $13 billion per year worldwide and more than $1 billion per month. Pfizer’s total annual revenue from Lipitor reached up to $7 billion per year in the United States Case 1:12-cv-105 17-RWZ Document 1 Filed 03/21/12 Page 1 of 38
-
Upload
barzilay123 -
Category
Documents
-
view
212 -
download
0